Cortical glutamatergic neurons mediate the motor sedative action of diazepam

Molecular Pharmacology

Volumn 73, Issue 2, 2008, Pages 282-291

  Zeller, A ^a   Crestani, F ^a   Camenisch, I ^a   Iwasato, T ^b,c   Itohara, S ^c   Fritschy, J M ^a   Rudolph, U ^a,d  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^d MCLEAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; DIAZEPAM; GLUTAMIC ACID; TRANSCRIPTION FACTOR EMX1;

ALLELE; ALPHA CHAIN; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; BETA CHAIN; BRAIN CORTEX; BRAIN REGION; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG MECHANISM; FOREBRAIN; GENE EXPRESSION; HIPPOCAMPUS; MOTOR ACTIVITY; MOUSE; MUTANT; NEOCORTEX; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; SEDATION; UPREGULATION; WILD TYPE;

ANIMALS; CEREBRAL CORTEX; DIAZEPAM; GLUTAMIC ACID; HYPNOTICS AND SEDATIVES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; NEURONS; RECEPTORS, GABA-A;

EID: 38549118598     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.107.038828     Document Type: Article

References (43)

1. A receptors: classification on the basis of subunit structure and function. Pharmacol Rev 50:291-313.
2. A receptor. Nat Rev Neurosci 6:565-575.
3. A receptors rendered diazepam-insensitive by point-mutated α-subunits. FEBS Lett 431:400-404.
4. Bosman L, Lodder JC, van Ooyen A, and Brussaard AB (2005a) Role of synaptic inhibition in spatiotemporal patterning of cortical activity. Prog Brain Res 147:201-204.
5. A receptor subtype have normal number of synapses, but retain juvenile IPSC kinetics until adulthood. J Neurophysiol 94:338-346.
6. A-receptor clustering results in enhanced anxiety and a bias for threat cues. Nat Neurosci 2:833-839.
7. Crestani F, Löw K, Keist R, Mandelli MJ, Möhler H, and Rudolph U (2001) Molecular targets for the myorelaxant action of diazepam. Mol Pharmacol 59:442-445.
8. Crestani F, Martin JR, Möhler H, and Rudolph U (2000) Mechanism of action of the hypnotic zolpidem in vivo. Br J Pharmacol 131:1251-1254.
9. Freund TF and Buzsaki G (1996) Interneurons of the hippocampus. Hippocampus 6:347-470.
10. A receptors containing the α1 subunit in Purkinje cells. J Neurosci 26:3245-3255.
11. A receptor α1 subunit. J Neurophysiol 88:3208-3217.
12. Heinke W, Kenntner R, Gunter TC, Sammler D, Olthoff D, and Koelsch S (2004) Sequential effects of increasing propofol sedation on frontal and temporal cortices as indexed by auditory event-related potentials. Anesthesiology 100:617-625.
13. Heinke W and Koelsch S (2005) The effects of anesthetics on brain activity and cognitive function. Curr Opin Anaesthesiol 18:625-631.
14. Hentschke H, Schwarz C, and Antkowiak B (2005) Neocortex is the major target of sedative concentrations of volatile anesthetics: strong depression of firing rates and increase of GABAA receptor-mediated inhibition. Eur J Neurosci 21:93-102.
15. A receptor produces synaptic and behavioral abnormalities in the mouse. Genes Brain Behav 4:10-19.
16. A receptor desensitization kinetics and its role in synapse function in rat cortical neurons. J Physiol 522:3-17.
17. Iwasato T, Nomura R, Ando R, Ikeda T, Tanaka M, and Itohara S (2004) Dorsal telencephalon-specific expression of Cre recombinase in PAC transgenic mice. Genesis 38:130-138.
18. A receptor subtype and state specificity. Proc Natl Acad Sci U S A 101:3674-3679.
19. A receptor α1 subunit knockout mice. J Clin Invest 115:774-779.
20. A receptor α1 subunit knockout mice. J Pharmacol Exp Ther 302:1037- 1045.
21. A receptor α1 subunit deletion alters receptor subtype assembly, pharmacological and behavioral responses to benzodiazepines and zolpidem. Neuropharmacology 43:685-694.
22. Kralic JE, Sidler C, Parpan F, Homanics GE, Morrow AL, and Fritschy JM (2006) Compensatory alteration of inhibitory synaptic circuits in cerebellum and thalamus of γ-aminobutyric acid type A receptor α1 subunit knockout mice. J Comp Neurol 495:408-421.
23. Lalonde R and Strazielle C (2001) Motor performance and regional brain metabolism of spontaneous murine mutations with cerebellar atrophy. Behav Brain Res 125:103-108.
24. Levin SI, Khaliq ZM, Aman TK, Grieco TM, Kearney JA, Raman IM, and Meisler MH (2006) Impaired motor function in mice with cell-specific knockout of sodium channel Scn8a (NaV1.6) in cerebellar Purkinje neurons and granule cells. J Neurophysiol 96:785-793.
25. A receptor modulator. Proc Natl Acad Sci U S A 102:7380-7385.
26. A receptors from mice lacking the γ2 subunit. J Physiol 527:11-31.
27. A receptor subtypes in the amygdala. Eur J Neurosci 20:1281-1289.
28. A receptor α1 subtype. Nat Neurosci 3:587-592.
29. A receptors in synapses of hippocampal pyramidal cells of the rat. Eur J Neurosci 13:428-442.
30. A receptors mediate phasic and tonic forms of inhibition in hippocampal pyramidal neurons. J Neurophysiol 96:846-857.
31. Rudolph U and Antkowiak B (2004) Molecular and neuronal substrates for general anaesthetics. Nat Rev Neurosci 5:709-720.
32. A receptor subtypes. Nature 401:796-800.
33. A receptor function and dissection of the pharmacology of benzodiazepines and general anesthetics through mouse genetics. Annu Rev Pharmacol Toxicol 44:475-498.
34. A receptor subtype functions. Curr Opin Pharmacol 6:18-23.
35. A receptor-mediated transmission onto CA1 interneurons in α1 subunit-null mice. Eur J Neurosci 25:3287-3304.
36. A receptor subtype selective benzodiazepine site ligand L-838417. Biopharm Drug Dispos 26:13-20.
37. A receptors: revived interest in the development of subtype-selective drugs. Curr Med Chem 5:217-242.
38. Stanley JL, Lincoln RJ, Brown TA, McDonald LM, Dawson GR, and Reynolds DS (2005) The mouse beam walking assay offers improved sensitivity over the mouse rotarod in determining motor coordination deficits induced by benzodiazepines. J Psychopharmacol 19:221-227.
39. A receptor α3 subunit-null mice. Eur J Neurosci 24:1307-1315.
40. A receptor subtype in the brain is not lethal in mice. J Neurosci 21:3409-3418.
41. A receptor subtype. Proc Natl Acad Sci U S A 98:6464-6469.
42. Trevor AJ and Way WL (1995) Sedative-hypnotic drugs, in Basic and Clinical Pharmacology (G Katzung ed) pp 333-349, Appleton & Lange, Norwalk, CT.
43. A receptor α1 subunit deletion prevents developmental changes of inhibitory synaptic currents in cerebellar neurons. J Neurosci 21:3009-3016.